Comparison between Blueblood Ventures IPO and Ganga Pharmaceuticals IPO.
Blueblood Ventures IPO is a SME Fixed Price IPO proposed to list at BSE SME while Ganga Pharmaceuticals IPO is a SME Fixed Price proposed to list at BSE SME.
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Quintessence Enterprise Pvt.Ltd. | First Overseas Capital Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Arch Finance Ltd. | Alacrity Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Blueblood Ventures IPO is up to ₹6.68 Cr whereas the issue size of the Ganga Pharmaceuticals IPO is up to ₹1.54 Cr. The final issue price of Blueblood Ventures IPO is ₹50.00 per share and of Ganga Pharmaceuticals IPO is ₹15.00 per share.
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹50.00 per share | ₹15.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 8000 shares |
| Fresh Issue Size | 13,35,000 shares | 10,24,000 shares |
| Fresh Issue Size (Amount) | up to ₹6.68 Cr | up to ₹1.54 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 13,35,000 shares | 10,24,000 shares |
| Issue Size Total (Amount) | up to ₹6.68 Cr | up to ₹1.54 Cr |
Blueblood Ventures IPO opens on Jan 21, 2016, while Ganga Pharmaceuticals IPO opens on Jan 29, 2016. The closing date of Blueblood Ventures IPO and Ganga Pharmaceuticals IPO is Jan 27, 2016, and Feb 09, 2016, respectively.
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 21, 2016 | Jan 29, 2016 |
| Issue Close | Jan 27, 2016 | Feb 09, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Feb 08, 2016 | Feb 22, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Blueblood Ventures IPO P/E ratio is , as compared to Ganga Pharmaceuticals IPO P/E ratio of .
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | 90.53 | 91.05 |
| Promoter Shareholding (Post-Issue) | 48.09 | 68.09 |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 0.01% | 1.27% |
In the Blueblood Ventures IPO Retail Individual Investors (RII) are offered 6,67,500 shares while in Ganga Pharmaceuticals IPO retail investors are offered 6,67,500 shares. Qualified Institutional Buyers (QIB) are offered in Blueblood Ventures IPO and in Ganga Pharmaceuticals IPO.
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 72,000 shares | 0 shares |
| QIB | ||
| NII | 6,67,500 shares | 5,12,000 shares |
| RII | 6,67,500 shares | 5,12,000 shares |
| Employee | ||
| Others | ||
| Total | 13,35,000 shares | 10,24,000 shares |
Blueblood Ventures IPO subscribed in total, whereas Ganga Pharmaceuticals IPO subscribed .
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
